DIO saw the highest growth of 0.16% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.16% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of DIO’s patent filings and grants. Buy the databook here.
DIO has been focused on protecting inventions in European Patent Office(EPO) with two publications in Q2 2024
The South Korea(KR), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where DIO is filings its patents. Among the top granted patent authorities, DIO has 100% of its grants in United States(US).
3Shape Holding and Align Technology could be the strongest competitors for DIO
In terms of grant share, DIO stands in eighth position among its competitors. 3Shape Holding and Align Technology secured the top positions according to recent patent publication data.
Patents related to healthtech and connected patient lead DIO's portfolio
DIO has the highest number of patents in healthtech followed by, connected patient and artificial intelligence. For healthtech no patents were filed and 40% of patents were granted in Q2 2024.
Image management related patents lead DIO portfolio followed by dental devices, and diagnostic imaging
DIO has highest number of patents in image management followed by dental devices, diagnostic imaging, autonomous driving, and active and passive safety.
For comprehensive analysis of DIO's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.